Skip to content
RT
Company

Updated:

RAPT Therapeutics, Inc.

RAPT Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001673772, and its reported industry...

Overview

RAPT Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001673772, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2025-03-06, it reported net income of USD -129,865,000; total assets of USD 240,325,000 for the fiscal period ended 2024-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

Company overview

Legal name
RAPT Therapeutics, Inc.
Former names in filing history
RAPT Therapeutics, Inc. (2019-05-24 to 2026-05-15); FLX Bio, Inc. (2016-05-05 to 2019-01-02)
Classification
Company
Industry (SIC)
2834 — Pharmaceutical Preparations
Headquarters
South San Francisco, CA, United States
Incorporated in
DE
Fiscal year end
December 31
SEC CIK
0001673772

Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

Fiscal yearPeriod endRevenueNet incomeTotal assetsCash and equivalentsOperating cash flow
FY2024USD—-$129.9M$240.3M$169.7M-$83.3M
FY2023USD$0-$116.8M$173.3M$47.5M-$97.0M
FY2022USD$1.5M-$83.8M$266.2M$38.9M-$70.8M
FY2021USD$3.8M-$69.2M$198.6M$24.0M-$61.0M

Recent SEC filings

FormFiledPeriodFiling
8-K8-K
8-K8-K
8-K8-K
8-K8-K
10-Q10-Q
8-K8-K
8-K8-K
8-K8-K
10-Q10-Q
8-K8-K
8-K8-K
8-K8-K

Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.

Research RAPT Therapeutics, Inc. in Altss

Track this company’s investors, transactions and relationships in Altss.

Book a demo

More Company profiles

RAPT Therapeutics, Inc. | Company | Altss